Superior vena cava replacement for epithelioid haemangioendothelioma

Interact Cardiovasc Thorac Surg. 2021 Oct 4;33(4):668-670. doi: 10.1093/icvts/ivab136.

Abstract

Epitheloid haemangiothelioma is extremely rare malignant tumour of vascular origin. Mediastinal location of this neoplasm with large veins involving is not common. We report a case of epitheloid haemangiothelioma in superior vena cava treated by radical resection and superior vena cava replacement with polytetrafluoroethylene prosthetic graft. There is a certain risk of neurological injury during the cross-clamping of superior vena cava in patient with incompletely obstructed veins. Venovenous shunt is a useful surgical strategy in this type of lesion without necessity of cardiopulmonary bypass use.

Keywords: Epitheloid haemangiothelioma; Superior vena cava replacement; Venovenous shunt.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blood Vessel Prosthesis Implantation* / adverse effects
  • Child
  • Hemangioendothelioma, Epithelioid*
  • Humans
  • Polytetrafluoroethylene
  • Sarcoma*
  • Vena Cava, Superior / diagnostic imaging
  • Vena Cava, Superior / surgery

Substances

  • Polytetrafluoroethylene